ribavirin has been researched along with guanidine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bisaillon, M; Bougie, I | 1 |
| Agudo, R; Domingo, E; Manrubia, SC; Perales, C; Tejero, H | 1 |
| Agudo, R; Domingo, E; Manrubia, SC; Perales, C | 1 |
| Domingo, E; Iranzo, J; Manrubia, SC; Perales, C | 1 |
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
1 review(s) available for ribavirin and guanidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for ribavirin and guanidine
| Article | Year |
|---|---|
Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase.
Topics: Adenosine Triphosphate; Binding Sites; Binding, Competitive; Catalysis; Circular Dichroism; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Guanidine; Hepacivirus; Interferon-alpha; Ions; Kinetics; Ligands; Nucleotides; Phosphorylation; Protein Binding; Ribavirin; Spectrometry, Fluorescence; Spectrophotometry; Thermodynamics; Time Factors | 2003 |
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
Topics: Animals; Antiviral Agents; Cell Line; Cricetinae; Evolution, Molecular; Foot-and-Mouth Disease Virus; Guanidine; Models, Biological; Mutagens; Mutation; Ribavirin; RNA, Viral; Virus Replication | 2009 |
Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus.
Topics: Animals; Antiviral Agents; Blotting, Western; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guanidine; Mutagenesis; Mutagens; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; RNA, Viral; Viral Load; Virus Replication | 2011 |
Tempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach.
Topics: Algorithms; Animals; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foot-and-Mouth Disease Virus; Guanidine; Models, Biological; Mutagens; Mutation; Ribavirin; Time Factors; Virus Replication | 2011 |
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |